Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Valuing the role of educators in practice: Greater Manchester's framework.
Williams C, Leigh J, Burns D, Halse J, Haydri S, Collins S, McManus E, Grundy J, Sutcliffe K, Bowler H, Blanc CL. Williams C, et al. Among authors: halse j. Br J Nurs. 2022 Feb 10;31(3):174-175. doi: 10.12968/bjon.2022.31.3.174. Br J Nurs. 2022. PMID: 35152744 No abstract available.
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. McClung MR, et al. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
Halse J, Greenspan S, Cosman F, Ellis G, Santora A, Leung A, Heyden N, Samanta S, Doleckyj S, Rosenberg E, Denker AE. Halse J, et al. J Clin Endocrinol Metab. 2014 Nov;99(11):E2207-15. doi: 10.1210/jc.2013-4009. Epub 2014 Aug 28. J Clin Endocrinol Metab. 2014. PMID: 25166719 Free PMC article. Clinical Trial.
[J. Halse replies].
Halse J. Halse J. Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):272. doi: 10.4045/tidsskr.14.0100. Tidsskr Nor Laegeforen. 2014. PMID: 24518466 Free article. Norwegian. No abstract available.
[Estrogen--a matter of the heart].
Halse J. Halse J. Tidsskr Nor Laegeforen. 2013 Sep 3;133(16):1686. doi: 10.4045/tidsskr.13.1015. Tidsskr Nor Laegeforen. 2013. PMID: 24005697 Free article. Norwegian. No abstract available.
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
Daniels LB, Grady D, Mosca L, Collins P, Mitlak BH, Amewou-Atisso MG, Wenger NK, Barrett-Connor E; Raloxifene Use for the Heart (RUTH) Trial Investigators. Daniels LB, et al. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):164-70. doi: 10.1161/CIRCOUTCOMES.112.966986. Epub 2013 Mar 12. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23481531 Free article. Clinical Trial.
[When should bisphosphonate treatment be discontinued?].
Eriksen EF, Halse J. Eriksen EF, et al. Among authors: halse j. Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1630-2. doi: 10.4045/tidsskr.11.0788. Tidsskr Nor Laegeforen. 2012. PMID: 22875131 Free article. Norwegian. No abstract available.
134 results